Clinical and molecular spectrum and prognostic outcomes of U2AF1 mutant clonal hematopoiesis- a prospective mayo clinic cohort study

Leuk Res. 2023 Feb:125:107007. doi: 10.1016/j.leukres.2022.107007. Epub 2022 Dec 28.

Authors

Affiliations

¹ Mayo Clinic, Department of Internal Medicine, Division of Hematology, Rochester, MN, USA.
² Mayo Clinic, Division of Hematology and Oncology, Jacksonville, FL, USA.
³ Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN, USA.
⁴ Mayo Clinic, Department of Internal Medicine, Division of Hematology, Rochester, MN, USA. Electronic address: [email protected].

PMID: 36586169
DOI: 10.1016/j.leukres.2022.107007

No abstract available

Keywords: BCOR; CCUS; CHIP; Clonal hematopoiesis; Splicing Genes; U2AF1.

MeSH terms

Clonal Hematopoiesis*
Cohort Studies
Hematopoiesis* / genetics
Humans
Mutation
Prognosis
Prospective Studies
Splicing Factor U2AF / genetics

Substances

Splicing Factor U2AF
U2AF1 protein, human